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Abstract 
 
 
Background/context: Experimental studies suggest that catastrophizing may worsen the 
prognosis of low back pain (LBP) and LBP-related disability, and increase the risk of 
chronicity.  
 
Purpose: To assess: a) The prognostic value of baseline catastrophizing for predicting the 
clinical evolution of LBP patients in routine clinical practice b) The association between 
the evolution of pain and catastrophizing.   
 
Study design/setting: Prospective study in routine clinical practice of the Spanish 
National Health Service. 
 
Patient sample: 1,422 acute and chronic adult LBP patients treated in primary and 
hospital care. 
 
Outcome measures: pain, disability and catastrophizing, measured through validated 
instruments. 
 
Methods: Patients were managed according to routine clinical practice. Outcome 
measures were assessed at baseline and 3 months later. Logistic regression models were 
developed to estimate the association between baseline catastrophizing score and the 
improvement of LBP and disability, adjusting for baseline LBP and leg pain severity, 
disability, duration of the pain episode, workers’ compensation coverage, radiological 
findings, failed back surgery, diagnostic procedures and treatments undertaken throughout 
the study. Another model was developed to estimate the association between the evolution 
of LBP and the change in catastrophizing, adjusting for the same possible confounders plus 
the evolution of leg pain and disability. Models were repeated excluding the treatments 
undergone after the baseline assessment.  
 
Results: Regression models showed that the degree of baseline catastrophizing does not 
predict the evolution of LBP and disability. Conversely, as the degree of pain improvement 
increases, so does the OR for improvement in catastrophizing, ranging from 3 (CI 95% 
2.00; 4.50, p<0.001) for improvements in pain between 1.1 and 4 VAS points, to 7.3 (CI 
95% 3.49; 15.36, p<0.001) for improvements in pain > 6.1. Similar results were obtained 
when treatments were excluded from the models. 
 
Conclusions. In routine practice, assessing the baseline score for catastrophizing does not 
help clinicians to predict the evolution of LBP and disability at 3 months. 
 
 
Key words: Low back pain, disability, prediction, catastrophizing, routine clinical 
practice. 
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Introduction 
 
Nonspecific or common low back pain (LBP) is defined as pain between the costal 
margins and the inferior gluteal folds, which may be associated with pain referred down to 
the leg (“leg pain”), and is usually accompanied by painful limitation of movement. 
Diagnosing common LBP implies that the pain is not related to conditions such as 
fractures, spondylitis, direct trauma, or neoplastic, infectious, vascular, metabolic, or 
endocrine-related processes.1   
 
Two of the main psychological factors which have been considered to negatively influence 
the prognosis of pain and disability in LBP patients, are fear-avoidance beliefs (FAB) and 
catastrophizing.1-9 FAB refer to the fear-induced avoidance of movements or activities 
which are expected to be painful, whereas catastrophizing is defined as an exaggerated 
negative mental state related to an actual or anticipated painful experience.1-9 In the 
Spanish cultural environment, FAB have shown to have an either negligible or non-
existent influence on LBP among elderly populations and among acute, subacute and 
chronic LBP patients treated in routine practice,10-13 whereas catastrophizing correlates 
with disability and explains approximately one fourth of its variance, 13,14  suggesting that it 
may have an influence on the prognosis of LBP patients. 
 
From a theoretical point of view, pre-existing catastrophizing thoughts may hamper 
patients’ clinical evolution. Conversely, it could also be hypothesized that catastrophizing 
would appear or be reinforced in patients who experience a disappointing clinical 
evolution, successive failed treatments and continued pain and disability. This poses a 
“chicken and egg” dilemma, on the potential reciprocal influence between catastrophizing 
and lack of clinical improvement.3,7-9 
 
In fact, previous cross-sectional studies have shown that catastrophizing, pain and 
disability correlate with each other,13-18 but results from prospective studies are 
inconsistent. Some randomized controlled trials and small studies in routine practice 
suggest that baseline catastrophizing is associated with the evolution of pain and disability, 
some suggest the contrary, and others conclude that catastrophizing predicts the outcome 
of acute LBP, but not before 6 weeks after the onset of pain.2,4,7,19-31 Results from the only 
large prospective study conducted in routine practice, suggest that baseline catastrophizing 
does not predict the evolution of LBP-related disability.32  
 
If catastrophizing were to actually have a negative influence on prognosis, it would follow 
that, in routine practice, clinicians should identify patients in whom psychological 
treatment to address catastrophizing should be considered. To this end, a cut-off value for 
baseline catastrophizing, above which reducing it would be required to treat LBP 
successfully, should be identified. 
 
Therefore, the objectives of this study were to: a) Determine whether assessing baseline 
catastrophizing would help clinicians to predict the clinical evolution of low back pain 
patients, in routine clinical practice, while establishing the cut-off point to identify subjects 
in whom catastrophizing may hinder recovery and should therefore be treated, b) Assess 
the association between improvement in pain and the evolution of catastrophizing.   
 
 
Methods 
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Setting 
 
This study was performed in 14 Health Care Centers from 7 different regions in Spain. 
Twelve belonged to the Spanish National Health Service (SNHS), and 2 to not-for-profit 
Foundations working for the SNHS.  
 
Participating centers included 6 primary care centers and 8 specialty centers in 
rehabilitation, neuroreflexotherapy, orthopedic surgery, and rheumatology. 
 
Subjects 
 
Inclusion criteria were: seeking care in a participating center for LBP with or without 
leg pain, not caused by direct trauma or systemic diseases, not complying with criteria 
for referral to surgery, and being able to read in Spanish.  
 
Pain not caused by systemic diseases was defined as pain in patients who had not been 
diagnosed with cancer, fibromyalgia or inflammatory diseases, such as rheumatoid 
arthritis or Bechterew’s disease (Ankylosing Spondylitis), and who did not show signs 
suggesting fibromyalgia or “red flags” for potential underlying systemic diseases.  
 
“Signs suggesting fibromyalgia” were defined as diffuse pain with unexplained fatigue or 
sleep disturbances, and “red flags” for potential underlying systemic diseases were 
defined as oncologic disease during the previous 5 years, constitutional symptoms 
(unexplained weight loss, fever, chills), history of intravenous drug use, or 
immunocompromised host.1,33-35  
 
Criteria for referral to surgery were defined as signs suggesting cauda equina syndrome, or 
nerve root compression due to disk herniation or spinal stenosis potentially qualifying for 
surgery. Relevant or progressive paresia, loss of sphincter control or saddle anesthesia, 
were considered as signs suggesting cauda equina syndrome. Potential surgical criteria for 
disk herniation were defined as disabling sciatic pain lasting 6 weeks or more, caused by 
a compromised nerve root demonstrated by magnetic resonance (MRI). Potential 
surgical criteria for symptomatic lumbar spinal stenosis were defined as radicular pain 
lasting 3 or more months, or claudication unrelated to peripheral vascular disease, with 
evidence of stenosis on MRI or CT scans.1  
 
Patients who had undergone unsuccessful spine surgery (“failed back surgery”) and 
those with “red flags” in which appropriate test procedures had ruled out systemic 
diseases, were invited to participate in the study. 
 
Exclusion criteria were: treated or untreated central nervous system impairment, refusal 
to sign the informed consent, and leaving a questionnaire assessing any of the variables 
unanswered.   
 
The design of this study did not imply any variation in the patients’ clinical 
management. Therefore, as opposed to randomized clinical trials, there were no ethical 
reasons for keeping the sample size as small as possible. As a result, sample size for this 
study was established at 1,500, in order to ensure enough statistical power, given that: a) 
previous studies had suggested that the potential effect of catastrophizing in Spanish 
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subjects could be small,10,11,16 b) approximately 80% of LBP patients treated in routine 
practice within the Spanish National Health Service, report a clinically relevant 
improvement at 3 months,36,37 and previous studies have shown that improvements are 
not normally distributed,36,38 which excludes linear regression analysis and implies the 
need to dichotomize continuous variables for logistic regression analyses, which in turn 
may reduce statistical power, d) this sample size would allow the introduction of up to 
30 variables in the regression models as potential confounders.39  
 
 
Procedure 
 
The study protocol was approved by the Ethical Committees of the participating Hospitals 
and institutions.  
 
All patients seeking care for LBP who were treated by physicians participating in this 
study, were screened for inclusion and exclusion criteria. The physicians explained the 
study’s characteristics to eligible patients, as well as how important it was for them to fully 
and accurately answer the questionnaires. They finally invited patients to sign the 
corresponding informed consent. The patients who signed it were included in the study. 
Neither patients nor recruiting physicians received any compensation for their participation 
in this study. 
 
Patients were assessed upon recruitment and three months later. At both assessments, 
patients completed all the self-administered questionnaires by themselves, in private. The 
only instructions they received, were those included in the standard validated versions of 
the self-administered questionnaires. They received no help or further directions from 
health care personnel, research staff or other third parties. Once completed, the 
questionnaires were collected by auxiliary personnel not related to the study. Data were 
introduced into a database at a central coordination office by two administrative assistants, 
who double-checked that the data introduced coincided with ratings on the questionnaires. 
 
Following routine practice conditions, all decisions on clinical management, including 
the prescription of any kind of diagnostic tests or treatments, were left up to the treating 
clinicians, and no measures were taken to homogenize their criteria. Clinicians had 
access to the scores for pain and disability, since these data can influence their clinical 
recommendations, but not to the score for catastrophizing. 
 
Variables 
 
At the first assessment, patients were asked to complete questionnaires gathering data on 
gender, age (date of birth), duration of current pain episode (days), and working status 
(classified as “not eligible”-i.e. students, housewives, unemployed, retired-, or “eligible for 
worker’s compensation benefits”, which in Spain can represent up to 100% of the salary 
irrespective of whether the worker is working or not –i.e., working, on sick leave or 
disabled-).  
 
In this study, LBP and leg pain severity, and LBP-related disability were considered the 
main indicators of patients’ clinical evolution.40 At both assessments, patients were asked 
to rate the intensity of low back pain (LBP), leg pain (LP), LBP-related disability, and 
catastrophizing. Pain intensity was measured with a 10-cm visual analog scale (VAS, for 
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which 0 = no pain and 10= worst possible pain).41 Low back pain-related functional 
disability was measured using the validated Spanish version of the Roland-Morris 
questionnaire (RMQ),42 in which disability is scored from 0 to 24 points (better to worse). 
Catastrophizing was measured using the catastrophizing subscale of the validated Spanish 
version of the Coping Strategies Questionnaire, in which patients’ use of catastrophizing 
strategies to cope with pain is scored from 0 (no use) to 36 (maximum possible use of 
those strategies).43  
 
Recruiting physicians provided data on patients’ radiological findings (no findings, disc 
degeneration, scoliosis, spondylolisthesis, spondylolysis, annular tear, disc protrusion, disc 
herniation, > 1 cm. difference in leg length, lumbarization of S1, sacralization of L5, other 
radiological findings), and history of failed back surgery related to current episode 
(yes/no), as well as diagnostic procedures (X-Rays, scanner, MRI, EMG, blood analyses, 
scintigraphy, other) and treatments which the patient had undergone throughout the study 
(drugs –NSAIDs, muscle relaxants, other drugs-, physiotherapy or rehabilitation, 
neuroreflexotherapy (NRT) intervention, surgery, other treatments).  
 
Analysis 
 
Absolute and relative frequencies were calculated for categorical variables, and mean and 
standard deviation (SD) for continuous ones. The characteristics of the patients who 
improved and did not improve were compared using the Mann-Whitney test for continuous 
variables. Categorical variables were compared through the chi-squared test, or the 
Fisher’s exact probability test when chi-squared was not applicable. 
 
Improvements in pain and disability were defined as any reduction in the score of VAS or 
RMQ being higher than the minimal clinically important change (MCIC). Previous studies 
have established MCIC for pain and disability at 30% of their baseline score, with a 
minimum value of 1.5 for VAS and 2.5 for RMQ.37 RMQ cannot be scored with decimals 
so, in this study, improvement was defined as “clinically relevant” when ≥1.5 VAS points 
or ≥3 RMQ points. Similarly, a “relevant reduction” in the CSQ score was defined as any 
reduction ≥ 30% of its baseline value.37,44 Since no data on MCIC for CSQ are available, a 
sensitivity analysis was conducted in which “change in the CSQ score” was defined as any 
positive difference between assessments at baseline and 3 months. According to these 
definitions, improvement was impossible when baseline scores were ≤ 1,5 VAS points for 
pain, ≤ 3 RMQ points for disability, or ≤ 1 CSQ point for catastrophizing. Therefore, 
patients with such a baseline score for a given variable, were excluded from the analysis 
which focused on the improvement of that variable.  
 
Two logistic regression models were developed to estimate the association between 
baseline CSQ score and the improvement of LBP and LBP-related disability during the 
study period, adjusting for other possible confounders. In order to relax the assumption of 
linearity among dependent variables and baseline CSQ, baseline CSQ score was 
categorized in quartiles and introduced into the models as dummy variables, using the first 
quartile as the reference one. 
 
At the design phase of this study, it was decided that all recorded variables that might exert 
an influence on the evolution of pain and disability, would be included as potential 
confounders in the models. These included gender, age (in years), baseline values for LBP 
(VAS points), leg pain (VAS points) and LBP-related disability (RMQ points), duration of 
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the current episode (collected in days and classified as acute –less than 14 days-, subacute 
–14 to 90 days-, chronic -91 to 365 days- and extremely chronic -over 365 days-),38,45 
workers’ compensation coverage, diagnosis of “failed back surgery”, radiological findings 
(disc degeneration, spondylolisthesis/spondylolysis, spinal stenosis, disc protrusion/hernia, 
no findings), diagnostic procedures performed throughout the study (X-Rays, MRI, CT 
scan, scintigraphy, electromyography, blood analysis), and treatments received before and 
during the study (NSAIDs, steroids, muscle relaxants, other drugs, physiotherapy, 
rehabilitation, NRT intervention, or surgery). In order to assess whether chronicity 
modified the association between baseline CSQ score and the evolution of pain and 
disability, the interaction between baseline CSQ score and chronicity was also included in 
the maximal model. CSQ was forced into a non-automatic backward elimination strategy 
oriented at providing a valid estimate, so that the variable with the highest P value that was 
not a confounder was excluded at every step.46,47 Variables were considered to be 
confounders if the estimate of the coefficient of CSQ changed by more than 10% when 
that variable was removed from the maximal model. In order to avoid the loss of statistical 
power, independent continuous variables were not categorized.48  
 
It was hypothesized that, although clinicians did not have access to patients’ baseline CSQ 
scores, the degree of baseline catastrophizing might have been linked to some patients’ 
characteristics which, in turn, could have influenced clinicians’ decisions with regards to 
treatment. Therefore, analyses were repeated excluding treatments received during the 
follow-up period. 
 
Another logistic regression model was developed to estimate the association between the 
evolution of LBP  (categorized in quartiles and introduced in the model as dummy 
variables), and the change in CSQ (defined as any change in the score being ≥ 30% of 
baseline value), adjusting for other possible confounders. In addition to all the potential 
confounders listed in the models described above, the maximal model also included the 
evolution of LP and disability. Evolution of LBP, LP and disability was defined as the 
baseline score minus the final one, so that positive values reflect improvement. Criteria 
used to consider a variable as a confounder were the same as described above. 
 
To validate these three models, the sample was randomly split into two sub-samples for 
each model. The first one (training sample) included 80% of patients. The second one 
(validation sample), included the remaining patients (i.e., 20%).47 Collinearity of the 
maximal model in training samples was evaluated using the criteria proposed by Belsley.49  
 
The SPSS v17 (SPSS Inc, Chicago, IL) was used for statistical analysis.  
 
Results 
 
Thirty three clinicians screened 1,565 patients. Sixty-five patients declined to commit to 
the follow-up visit and did not sign the informed consent. The remaining 1,500 (95.67%) 
patients were included. There were no losses to follow-up, but 78 subjects (5.2%) were 
excluded at the analysis phase for having left questionnaires on LBP (32 patients), LP (47), 
disability (39), catastrophizing (34), or workers’ compensation coverage (4), unanswered. 
Sixty-two out of those 78 patients left two or more questionnaires unanswered. Therefore, 
1,422 patients were included in the analysis. Their mean age was 52.6 years, and most 
were women (62.6%) with chronic LBP (58.4%). At baseline, their mean CSQ score was 
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15 points, although 143 patients (10.1%) had a CSQ score over 75% of the maximum 
possible. Patients’ baseline characteristics are shown in Table 1.  
 
At baseline, 24 patients had a pain score ≤  1,5 VAS points, 77 had a disability score ≤  3 
RMQ points, and 6 had a score on the CSQ ≤ 1. Therefore, they were excluded from the 
analysis focusing on the improvement of the corresponding variable (Table 2). Pain 
worsened in only 36 patients (2.5% of the sample), disability in 40 (2.8%) and 
catastrophizing in 91 (6.4%). Therefore, no separate analyses were made for these patients 
and they were included in the “did not improve” category for the corresponding variable.  
 
There were some differences between patients who experienced improvements in pain, 
disability and catastrophizing, and those who did not (Table 2). Among patients who 
improved, failed back surgery was less common, diagnostic procedures were less 
frequently performed, and the treatments prescribed differed from those undergone by 
patients who did not improve. In addition, among the 1,043 patients in whom pain 
improved throughout the study period, baseline pain severity was higher, fewer were 
chronic, and fewer showed disk protrusion or hernia on MRI. Among the 879 in whom 
disability improved, baseline RMQ scores were higher and fewer showed no radiological 
findings in imaging. Among the 1,010 in whom catastrophizing improved, baseline CSQ 
scores were higher, leg pain was more common, and fewer showed no radiological 
findings in imaging (Table 2). 
 
The model analyzing the association between baseline catastrophizing and the evolution of 
low back pain had to be adjusted by baseline severity of low back pain, baseline degree of 
disability, and whether the patient received NRT intervention. The training sample 
included 1,103 patients, and the validation one, 295. There were no collinearity  problems. 
No association was found between baseline CSQ score and the evolution of LBP (Table 3). 
This was the case for both the training and validation samples. When treatments were 
removed from the model, changes in results were minor (Table 3). 
 
The model analyzing the association between baseline catastrophizing and the evolution of 
disability, had to be adjusted by baseline score for disability, and whether the patient 
received NRT intervention. The training sample included 1,088 patients, and the validation 
one, 257. There were no collinearity  problems. No association was found between 
baseline CSQ and the evolution of  disability (Table 4). This was the case for both the 
training and validation samples. When treatments were removed from the model, changes 
in results were minor (Table 4). 
 
The last regression model showed that the evolution of catastrophizing throughout the 
study period was associated with the evolution of LBP (Table 5). The training sample 
included 1,124 patients and the validation one, 292. As the degree of pain improvement 
increased, so did the OR for improvement in catastrophizing, ranging from 3 (CI 95% 
2.00; 4.50, p<0.001) for improvements in pain between 1.1 and 4 VAS points, to 7.3 (CI 
95% 3.49; 15.36, p<0.001) for improvements in pain > 6.1 VAS points (Table 5). The ORs 
(95% CI) in the validation sample were similar to the ones found in the training sample 
(data not shown). When treatments were removed from the model, changes in results were 
minor (Table 5). There were no collinearity  problems. In the sensitivity analysis in which 
“change” in the CSQ score was defined as “any change”, instead of a variation ≥ 30% of 
its baseline score, the results were virtually identical (Table 5). 
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Among the 34 patients who left the CSQ unanswered at the follow-up assessment, 27 had 
answered it at the baseline assessment and their median (IQR) score was 7 (2,11). The 
baseline CSQ score was unknown for only 7 patients (0.5%). Therefore, it was decided not 
to perform a sensitivity analysis.  
 
 
Discussion  
 
Results from this study show that baseline catastrophizing is of no clinical value for 
predicting the evolution of low back pain (LBP) and disability. Hence, it is not appropriate 
to use catastrophizing for early identification of those patients with a bad clinical 
prognosis.  
 
“Association” is different from “causality”. Therefore, results from this study might be 
interpreted as suggesting that improvement in pain leads to improvement in 
catastrophizing, or viceversa. However, from both a psychological and a biological 
perspective, it is more likely that catastrophizing may appear or worsen when pain does 
not improve despite treatments received. The fact that the baseline degree of 
catastrophizing does not predict the evolution of pain and disability (Tables 3 and 4), 
further supports this interpretation. However, it might be argued that, in patients with a 
higher degree of catastrophizing, pain needs to improve further before they notice any 
improvement, and that the placebo effect may be smaller or shorter. Therefore, further 
studies should assess the potential influence of catastrophizing on the minimal clinically 
important change for pain and disability, and on the size and duration of the placebo effect. 
 
These results suggest that the correlation previously found between catastrophizing, LBP 
and LBP-related disability in cross-sectional studies,13-18 may be of little practical clinical 
value, since it might be explained by the fact that the OR for improvement in 
catastrophizing increases with pain improvement (Table 5). Results from a study 
conducted in the same cultural setting, showed that the correlation of catastrophizing and 
other psychological variables with disability, ceases to be significant when variations of 
trait anxiety are taken into account, suggesting  that other psychological variables may play 
a more relevant role than catastrophizing.50 This is also consistent with results from a large 
study conducted in routine practice in the Anglo-Saxon cultural context, which showed 
that among 20 potential psychological obstacles to recovery, only 4 (including neither 
FAB nor catastrophizing) were predictive of the clinical evolution of disability.32 Results 
from randomized controlled trials and small prospective studies are inconsistent.2,4,7,12,18-31 
Differences in sample size, recruitment context (e.g., patients treated in routine practice vs. 
secondary analyses of data gathered in clinical trials), patients’ characteristics, and 
statistical methods used across studies (e.g., use of hierarchical vs. non-hierarchical 
models) can account for this inconsistency. For instance, the use of hierarchical models 
implies pre-hoc assumptions and favors those variables which the authors choose to enter 
first, since these have a greater chance of attaining statistical significance. 
 
It seems theoretically plausible that catastrophizing may be influenced by the duration of 
pain, the radiological findings (and potential explanations given to the patients with 
regards to it), and having undergone aggressive treatments. However, in this study 
catastrophizing scores were not influenced by these variables. In fact, the association 
between pain improvement and catastrophizing was the same among acute and chronic 
patients, and the prognostic value of baseline catastrophizing for predicting the clinical 
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evolution was null among both acute and chronic patients (Tables 3-5). Results from the 
logistic regression models showed that the only relevant feature with respect to the 
evolution of catastrophizing, is whether pain severity improves (Table 5). This might be 
interpreted as suggesting that patients do not tend to catastrophize if pain severity is 
improving, independently of its duration. 
 
The objective of this study was to appraise the usefulness of assessing catastrophizing in 
the management of LBP patients in routine clinical practice. As a result, all kinds of LBP 
patients were included in this study; acute and chronic, with and without leg pain, having 
undergone unsuccessful spine surgery or not, etc. However, regression models show that 
none of these characteristics influence the null prognostic value of baseline catastrophizing 
for predicting patients’ clinical evolution. At the design phase it was also decided that this 
study should be conducted in conditions as close as possible to routine practice in the 
Spanish National Health Service (SNHS). As a result, patients were managed as they 
usually are in routine practice, and clinical decisions were left up to the treating physician. 
However, LBP-related clinical practice is roughly consistent within the SNHS, and it 
generally follows current evidence-based guidelines.36,51,52  The seven Spanish regions in 
which this study was conducted represent most of the economic and cultural spectrum of 
the country. Acute (41.9%) and chronic (58.1%) patients were recruited in routine 
clinical practice, in primary and specialty centers belonging to or working for the 
SNHS. The SNHS is a tax-funded public organization in which all health care services are 
provided free to every resident in Spain (except aesthetic surgery and some dental 
procedures). 36 Only a small minority of patients in the upper economic class seek health 
care exclusively through private health care. Low rates of included patients among those 
screened, losses to follow-up and missing data, may introduce a risk of bias. In this study, 
over 95% of the patients screened were included, there were no losses to follow-up, and 
only 78 out of 1,500 patients (5.2%) were excluded from the analysis due to missing data. 
All these features suggest that generalizability of these results to LBP patients treated 
within the SNHS should not be a concern.  
 
It has been suggested that the role of psychological variables in the evolution of LBP, may 
vary across cultural contexts. In fact, while associations between LBP and catastrophizing 
have been observed in some studies conducted in the Northern European and Anglo-Saxon 
cultural contexts.2-4,7,20-31,53-56, to date no psychological variable has shown to be relevant 
with regards to the treatment or clinical evolution of LBP patients in the Spanish context.11-
13,18Therefore, further studies should assess the generalizability of current results to other 
cultural environments, and identify which psychological variables influence the prognosis 
of LBP in the Spanish cultural context. Those studies should be longitudinal, include large 
representative samples of acute and chronic patients recruited in clinical practice and use 
non-hierarchical models, in order to be comparable with the current one and to lead to 
results which are potentially relevant to clinical practice. 
 
According to the results of this study, a high baseline score for catastrophizing does not 
predict the clinical course of pain or disability (Tables 3 and 4), whereas improvement in 
pain is associated with a higher OR for improvement in catastrophizing (Table 5). This 
might be interpreted as suggesting that it is more likely that a high score in catastrophizing 
follows lack of improvement in pain, than that a high baseline catastrophizing score 
hinders improvement in pain or disability. This interpretation would contribute to the 
“chicken and egg dilemma” debate with regards to the potential reciprocal influence 
between catastrophizing and lack of clinical improvement.3,7-9  
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The strengths of this study include its large sample, the low number of exclusions, losses to 
follow-up and missing data, and generalizability of its results to routine clinical practice. 
Weaknesses are its observational design, relatively short follow-up, that catastrophizing 
was the only psychological variable assessed, that continuous variables had to be 
dichotomized at the analysis stage, and the lack of evidence on the size of the minimal 
clinically important change (MCIC) for catastrophizing. These potential limitations are 
discussed in the following paragraphs.   
 
Some patients included in this study showed high levels of catastrophizing and low levels 
of pain and disability at baseline, while others showed the opposite (Tables 1 and 2). The 
large sample size and the absence of losses to follow-up, allowed the identification of 
sizeable subgroups comprising those in whom each variable improved and did not improve 
throughout the study period. This allowed this study to assess the prognostic value of 
baseline catastrophizing for predicting the evolution of pain and disability, despite its 
observational design.  
 
Chronic patients generate most of the social and economic burden associated with 
LBP.57,58 Therefore, in this study follow-up was planned at 3 months to ensure that all 
patients who were still symptomatic at the follow-up assessment would be chronic,45 and 
to minimize the risk of losses associated with longer follow-up periods within the routine 
clinical practice of the SNHS.36  However, since baseline catastrophizing does not predict 
the clinical evolution of pain or disability during the first three months, it is not likely for it 
to become relevant at a later stage. In fact, the prognosis of chronic low back pain is 
determined by changes in pain and disability occurring in the initial period.59 
 
Catastrophizing might influence other psychological variables which have not been 
assessed in this study and which may influence patients’ general health and well being, 
such as fear, anxiety or depression.20,21,52,53,60-62 Therefore, although catastrophizing score 
cannot be used to identify those patients in whom LBP has a worse prognosis, it may still 
be useful to identify those subjects with underlying emotional or psychological 
comorbidities. Further studies should compare the validity, reliability and feasibility of 
measuring catastrophizing or other psychological variables (e.g., anxiety or depression) to 
identify these patients in routine practice. On the other hand, results from this study show 
that the improvement of pain is associated with the improvement of catastrophizing, 
suggesting that successfully treating pain might be an effective way of improving 
catastrophizing and other potentially related psychological variables. Further studies 
should test this hypothesis. 
 
Continuous variables had to be dichotomized into categories for logistic regression 
analyses. This might have led to a loss of statistical power. Anticipating this, a large 
sample was established at the design phase, and measures to reduce missing data and 
losses to follow-up were planned and successfully implemented. In fact, statistical power 
was enough to show that pain improvement is associated with the evolution of 
catastrophizing (Table 5). 
 
Previous studies have shown that the cut-off point to consider a change in pain as 
“clinically relevant”, corresponds to 30% of its baseline value, and that the same criterion 
is valid for disability.37,44 Therefore, at the design phase of this study it was decided to 
establish the same cut-off point for catastrophizing. It was also decided to perform a 
13 
 
sensitivity analysis in which “any positive change” –regardless of its size- would be 
considered as clinically relevant. Results from analyses using both cut-off points are 
consistent, which suggests that the lack of previous evidence on the MCIC for 
catastrophizing does not challenge the validity of results from this study (Table 5). 
 
In conclusion, this study shows that, in routine clinical practice, assessing baseline 
catastrophizing does not help clinicians to predict the evolution of LBP and disability at 3 
months.  
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Table 1. Baseline characteristics of patients included in the study 
 
Variables All patients (n = 1422) 
Gender (males) * 
Age (years) ¤ 
Eligible for workers’ compensation 
Duration of pain * 
   Acute (< 14 days) 
   Subacute (14-90 days) 
   Chronic: 
        91-365 days 
        > 365 days 
 
Failed back syndrome * 
Findings on imaging tests * 
   No findings 
   Disc degeneration 
   Spondylolisthesis/spondylolysis    
   Spinal stenosis  
   Disc protrusion/herniation  
   Annular tear  
   > 1cm difference in leg length 
   Lumbarization of S1 
   Sacralization of L5 
   Other radiological findings  
 
Diagnostic procedures * 
   X-Rays 
   Magnetic Resonance 
   CT-scan 
   Electromiography 
   Blood analysis 
   Scintigraphy 
    
Drug treatment * 
   NSAIDs 
   Corticoids 
   Muscle relaxants 
   Other 
Physiotherapy or rehabilitation * 
Neuro-reflexotherapy * 
Surgery * 
Other treatments* 
    
LBP (VAS) ¤ 
LP (VAS) (n= 1098) ¤ 
Disability (RMQ) ¤ 
Catastrophizing (CSQ) ¤ 
532 (37.4) 
52.6 (15.0) 
824 (58.0) 
 
113 (7.9) 
479 (33.7) 
 
553 (38.9) 
277 (19.5) 
 
21 (1.5) 
 
255 (17.9) 
890 (62.6) 
91 (6.4) 
118 (8.3) 
485 (34.1) 
3 (0.2) 
12 (0.8) 
14 (1.0) 
9 (0.6) 
15 (1.1) 
 
 
359 (25.2) 
355 (25.0) 
50 (3.5) 
58 (4.1) 
53 (3.7) 
3 (0.2) 
 
 
806 (56.7) 
96 (6.8) 
274 (19.3) 
139 (9.8) 
176 (12.4) 
1242 (87.3) 
8 (0.6) 
15 (1.1) 
 
6.7 (2.1) 
6.2 (2.4) 
12.8 (5.6) 
15.0 (8.5) 
* Frequency (%)   ¤ Mean (SD)  LBP: Severity of low back pain   LP: Severity of referred pain down 
into the leg (leg pain) (in the 1098 patients who had it)  RMQ: Score in the Roland-Morris 
Questionnaire  CSQ: Score in the Coping Strategies Questionnaire 
 
 
 
 
 
19 
 
 
 
Table 2. Baseline characteristics of patients in whom low back pain, disability and catastrophizing 
improved and did not improve throughout the study. 
 
Variable LBP improved 
(n =1043) † LBP did not improve 
(n =355) † 
p Disability 
improved 
(n =879) ‡ 
Disability did 
not improve 
(n =466) ‡ 
p Catastrophizing 
improved 
(n =1010) ¥ 
Catastrophizing 
did not improve 
(n =406) ¥ 
p 
Gender (males) * 
Age (years) ¤ 
Eligible for workers’ compensation 
 
Chronicity * 
   < 14 days 
   14-90 days 
   91-365 days 
   > 365 days 
 
Failed back surgery * 
 
Findings on imaging tests * 
   Disc degeneration 
   Spondylolisthesis/spondylolysis    
   Spinal stenosis  
   Disc protrusion/hernia   
   Annular tear  
   > 1cm difference in leg length 
   Lumbarization of S1 
   Sacralization of L5 
   No finding 
    
 
Diagnostic procedures * 
   X-Rays 
   Magnetic Resonance 
   CT scan 
   Electromiography 
   Blood analysis 
   Scintigraphy 
 
 
Drug treatment * 
   NSAIDs 
   Corticoids 
   Muscle relaxants 
   Other 
Physiotherapy or rehabilitation * 
Neuro-reflexotherapy * 
Surgery * 
Other treatments* 
   
Severity of LBP (VAS) ¤ 
Patients with LP* 
Severity of LP (VAS)¤ 
Disability (RMQ) ¤ 
Catastrophizing (CSQ) ¤ 
391 (37.5) 
52 (41;63) 
598 (57.3) 
 
 
91 (8.7) 
362 (34.7) 
403 (38.6) 
187 (17.9) 
 
8 (0.8) 
 
 
662 (63.5) 
71 (6.8) 
79 (7.6) 
330 (31.6) 
2 (0.2) 
8 (0.8) 
9 (0.9) 
6 (0.6) 
177 (17.0) 
 
 
 
223 (21.4) 
230 (22.1) 
23 (2.2) 
25 (2.4) 
22 (2.1) 
2 (0.2) 
 
 
 
584 (56.0) 
51 (4.9) 
183 (17.5) 
100 (9.6) 
101 (9.7) 
975 (93.5) 
3 (0.3) 
7 (0.7) 
 
7 (6;8) 
775 (74.4) 
7 (5;8) 
14 (0;18) 
16 (9;22) 
126 (37.2) 
52 (41;64) 
207 (58.6) 
 
 
18 (5.1) 
105 (29.6) 
146 (41.1) 
86 (24.2) 
 
13 (3.7) 
 
 
221 (62.3) 
19 (5.4) 
38 (10.7) 
145 (40.8) 
0 (0) 
3 (0.8) 
4 (1.1) 
2 (0.6) 
70 (19.7) 
 
 
 
127 (35.8) 
114 (32.1) 
26 (7.3) 
28 (7.9) 
28 (7.9) 
0 (0) 
 
 
 
209 (58.9) 
41 (11.5) 
84 (23.7) 
39 (11.0) 
70 (19.7) 
258 (72.7) 
5 (1.4) 
6 (1.7) 
 
6 (4;8) 
247 (69.6) 
1 (0;.6) 
12 (8;16) 
13 (7;19) 
0.501 
0.983 
0.668 
 
0.006 
 
 
 
 
 
<0.001 
 
 
0.681 
0.335 
0.066 
0.002 
1.000 
1.000 
0.749 
1.000 
0.241 
 
 
 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
1.000 
 
 
 
0.344 
<0.001 
0.011 
0.447 
<0.001 
<0.001 
0.029 
0.106 
 
<0.001 
0.078 
0.154 
0.451 
0.443 
333 (37.9) 
52 (41;63) 
519 (59.0) 
 
 
71 (8.1) 
307 (34.9) 
341 (38.8) 
160 (18.2) 
 
8 (0.9) 
 
 
546 (62.1) 
55 (6.3) 
74 (8.4) 
298 (33.9) 
2 (0.2) 
7 (0.8) 
8 (0.9) 
4 (0.5) 
142 (16.2) 
 
 
 
178 (20.3) 
206 (23.4) 
18 (2.0) 
21 (2.4) 
17 (1.9) 
2 (0.2) 
 
 
 
492 (56.0) 
42 (4.8) 
169 (19.2) 
84 (9.6) 
86 (9.8) 
832 (94.7) 
3 (0.3) 
5 (0.6) 
 
7 (5;8) 
647 (73.7) 
6 (2;8) 
14 (10;18) 
15 (9;21) 
167 (35.8) 
53 (43;65) 
255 (55.0) 
 
 
30 (6.4) 
143 (30.7) 
193 (41.4) 
100 (21.5) 
 
13 (2.8) 
 
 
314 (67.4) 
33 (7.1) 
41 (8.8) 
169 (36.3) 
1 (0.2) 
3 (0.6) 
6 (1.3) 
5 (1.1) 
88 (18.9) 
 
 
 
157 (33.7) 
134 (28.8) 
28 (6.0) 
32 (6.9) 
31 (6.7) 
1 (0.2) 
 
 
 
278 (59.7) 
47 (10.1) 
94 (20.2) 
54 (11.6) 
78 (16.7) 
365 (78.3) 
5 (1.1) 
9 (1.9) 
 
7 (5;8) 
348 (74.7) 
5 (2;8) 
12 (8;16) 
14 (8;20) 
0.460 
0.071 
0.149 
 
0.177 
 
 
 
 
 
0.008 
 
 
0.056 
0.561 
0.813 
0.386 
1.000 
1.000 
0.576 
0.290 
0.026 
 
 
 
<0.001 
0.033 
<0.001 
<0.001 
<0.001 
1.000 
 
 
 
0.194 
<0.001 
0.677 
0.243 
<0.001 
<0.001 
0.134 
0.025 
 
0.290 
0.694 
0.481 
<0.001 
0.028 
378 (37.4) 
53 (42;64) 
585 (57.9) 
 
 
82 (8.1) 
341 (33.8) 
394 (39.0) 
193 (19.1) 
 
8 (0.8) 
 
 
651 (64.5) 
63 (6.2) 
84 (8.3) 
333 (33.0) 
1 (0.1) 
9 (0.9) 
7 (0.7) 
6 (0.6) 
160 (15.8) 
 
 
 
213 (21.1) 
226 (22.4) 
21 (2.1) 
21 (2.1) 
17 (1.7) 
1 (0.1) 
 
 
 
550 (54.5) 
44 (4.4) 
163 (16.1) 
93 (9.2) 
92 (9.1) 
947 (93.8) 
2 (0.2) 
6 (0.6) 
 
7 (5;8) 
754 (74.7) 
5 (1;8) 
13 (9;17) 
15 (8;21) 
152 (37.4) 
50 (40;62) 
235 (58.2) 
 
 
30 (7.4) 
137 (33.7) 
157 (38.7) 
82 (20.2) 
 
12 (3.0) 
 
 
238 (58.6) 
28 (6.9) 
34 (8.4) 
151 (36.9) 
2 (0.5) 
2 (0.5) 
4 (1.0) 
2 (0.5) 
94 (23.2) 
 
 
 
141 (34.7) 
126 (31.0) 
28 (6.9) 
35 (8.6) 
34 (8.4) 
2 (0.5) 
 
 
 
254 (62.6) 
51 (12.6) 
109 (26.8) 
46 (11.3) 
81 (20.0) 
295 (72.7) 
6 (1.5) 
9 (2.2) 
 
7 (5;8) 
277 (78.2) 
5 (2;7) 
13 (8;17) 
14 (8;20) 
0.996 
0.035 
0.932 
 
0.944 
 
 
 
 
 
0.002 
 
 
0.040 
0.647 
0.972 
0.130 
0.199 
0.738 
0.522 
0.818 
0.001 
 
 
 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
0.199 
 
 
 
0.005 
<0.001 
<0.001 
0.225 
<0.001 
<0.001 
0.009 
0.017 
 
0.009 
0.013 
0.911 
0.970 
<0.001 
* Frequency (%)   ¤ Median (p25;p75)  LBP: Low back pain   LP: Referred pain down into the leg (in the 1098 
patients who had it)  RMQ: Score in the Roland-Morris Questionnaire  CSQ: Score in the Coping 
Strategies Questionnaire † Only includes patients whose pain severity at baseline was high enough 
to allow for a clinically relevant improvement (i.e., baseline VAS > 1.5). ‡ Only includes patients 
whose disability at baseline was high enough to allow for a clinically relevant improvement (i.e., 
baseline RMQ > 3).  ¥ Only includes patients whose catastrophizing at baseline was high enough 
to allow for improvement (i.e., baseline CSQ ≥ 1). 
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Table 3. Association between catastrophizing at baseline, and the evolution of the severity of low 
back pain throughout the study period (3 months). 
 
 Crude analysis Adjusted analysis** 
 OR (CI 95%) p OR (CI 95%) P 
Catastrophizing 
at baseline* 
 Q1 (≤8) 
 Q2 (9-15) 
 Q3 (16-21) 
 Q4 (≥22) 
 
 
Ref. cat 
1.42 (0.99; 2.02) 
1.13 (0.79; 1.61) 
1.28 (0.88; 1.85) 
0.253 
 
 
0.055 
0.502 
0.197 
 
 
Ref. cat 
0.87 (0.58; 1.31) 
0.66 (0.43; 1.01) 
0.63 (0.39; 1.02) 
0.163 
 
 
0.509 
0.056 
0.060 
*: Categorized in quartiles.  
**: Variables included in the model were: gender, age, baseline values for LBP, leg pain  and LBP-
related disability, duration of the current episode (acute, subacute, chronic and extremely 
chronic), the interaction between baseline CSQ and chronicity, workers’ compensation coverage, 
diagnosis of “failed back surgery”, radiological findings, diagnostic procedures performed 
throughout the study, and treatments received. Results had to be adjusted only by baseline 
severity of low back pain, baseline degree of disability, and having undergone neuro-
reflexotherapy intervention. OR’s for these variables are not shown, since they may have been 
confounded by unknown variables which were not controlled for.24  
 
In the model in which prescribed treatments were removed from the models, only baseline severity 
of low back pain showed a confounding effect, and changes in results were minor [adjusted global 
p: 0.080, and adjusted OR (CI95%) for Q2, Q3 and Q4: 1.16 (0.80;1.69), 0.81 (0.55;1.18) and 0.71 
(0.47;1.07), respectively]. 
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Table 4. Association between catastrophizing at baseline, and the evolution of disability throughout 
the study period (3 months).  
 
 Crude analysis Adjusted analysis** 
 OR (CI 95%) p OR (CI 95%) P 
Catastrophizing 
at baseline* 
Q1 (≤8) 
 Q2 (9-15) 
 Q3 (16-20) 
 Q4 (≥21) 
 
 
Ref. cat 
1.43 (1.04; 1.97) 
1.71 (1.21; 2.41) 
1.73 (1.24; 2.40) 
0.003 
 
 
0.028 
0.002 
0.001 
 
 
Ref. cat 
0.87 (0.61; 1.23) 
0.76 (0.51; 1.12) 
0.64 (0.43; 0.96) 
0.167 
 
 
0.428 
0.167 
0.029 
*: Categorized in quartiles.  
**: Variables included in the maximal model were: gender, age, baseline values for LBP, leg pain  
and LBP-related disability, duration of the current episode (acute, subacute, chronic and 
extremely chronic), the interaction between baseline CSQ and chronicity, workers’ compensation 
coverage, diagnosis of “failed back surgery”, radiological findings, diagnostic procedures 
performed throughout the study, and treatments received. Results had to be adjusted only by 
baseline degree of disability, and having undergone neuro-reflexotherapy intervention. OR’s for 
these variables are not shown, since they may have been confounded by unknown variables 
which were not controlled for.24 
 
In the model in which prescribed treatments were removed from the models, only baseline severity 
of disability showed a confounding effect, and changes in results were minor [adjusted global p: 
0.459, and adjusted OR (CI95%) for Q2, Q3 and Q4: 1.14 (0.82;1.60), 1.01 (0.70;1.47) and 0.85 
(0.58;1.25), respectively] 
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Table 5. Association between the evolution of the severity of low back pain and the improvement of 
catastrophizing.†  
 
 
 Crude analysis Adjusted analysis** 
 OR (CI 95%) p OR (CI 95%) P 
Evolution of 
severity of LBP* 
Q1 (≤1.0) 
 Q2 (1.1-4.0) 
 Q3 (4.1-6.0) 
 Q4 (≥6.1) 
 
 
Ref. cat 
4.97 (3.54; 6.97) 
10.61 (6.92; 16.27) 
35.87 (18.65; 68.98) 
<0.001 
 
 
<0.001 
<0.001 
<0.001 
 
 
Ref. cat 
3.00 (2.00; 4.50) 
3.18 (1.91; 5.29) 
7.32 (3.49; 15.36) 
<0.001 
 
 
<0.001 
<0.001 
<0.001 
*: Categorized in quartiles. The evolution of LBP was defined as the baseline score minus the final 
one, so that positive values reflect improvement. 
**: Variables included in the maximal model were: gender, age, baseline values for LBP, leg pain  
and LBP-related disability, duration of the current episode (acute, subacute, chronic and 
extremely chronic), the interaction between baseline CSQ and chronicity, workers’ compensation 
coverage, diagnosis of “failed back surgery”, radiological findings, diagnostic procedures 
performed throughout the study, treatments received, the evolution of referred pain and the 
evolution of disability. Results had to be adjusted only by baseline degree of disability, 
improvement in disability throughout the study period, and having undergone neuro-
reflexotherapy intervention. OR’s for these variables are not shown, since they may have been 
confounded by variables which were not controlled for.24 
 
† Defining “improvement” as any reduction in the CSQ score being ≥ 30% of its baseline value. In 
the sensitivity analyses in which “improvement” was defined as “any reduction in the CSQ score” –
regardless of its size-, results had to be adjusted only by improvement in disability throughout the 
study period and adjusted ORs (CI 95%) for Q2, Q3 and Q4 were: 2.87 (1.91;4.32), 4.04 
(2.28;7.16) and 5.49 (2.46;12.24), respectively.  
 
In the model in which prescribed treatments were removed from the models, only baseline degree 
of disability and improvement in disability throughout the study period showed a confounding effect, 
and changes in results were minor [adjusted global p: <0.001, and adjusted OR (CI95%) for Q2, Q3 
and Q4: 3.43 (2.30;5.10), 4.06 (2.48;6.66) and 9.58 (4.62;19.84), respectively] 
 
 
 
 
 
